Rezolute (RZLT) Interest Coverage Ratio Growth (1y) (2013 - 2019)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 95.84% |
| Mar 31, 2019 | 96.89% |
| Dec 31, 2018 | 99.99% |
| Sep 30, 2016 | -17.19% |
| Jun 30, 2016 | -155.16% |
| Mar 31, 2016 | -194.79% |
| Dec 31, 2015 | -120.90% |
| Sep 30, 2015 | 54.24% |
| Jun 30, 2015 | 62.38% |
| Mar 31, 2015 | -237,763.95% |
| Dec 31, 2014 | -127,896.85% |
| Sep 30, 2014 | -105,017.38% |
| Jun 30, 2014 | -75,899.61% |
| Mar 31, 2014 | 97.92% |
| Dec 31, 2013 | 77.18% |
| Sep 30, 2013 | 17.83% |
| Jun 30, 2013 | -401.40% |
| Mar 31, 2013 | -2,063.78% |